The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Analysis of mutations in formalin-fixed paraffin-embedded (FFPE) tumor samples from two phase II clinical trials using a Sequenom-based approach.
Maria Orr
Employment or Leadership Position - AstraZeneca
Stock Ownership - AstraZeneca
James Sherwood
Employment or Leadership Position - AstraZeneca
Stock Ownership - AstraZeneca
Gael McWalter
Employment or Leadership Position - AstraZeneca
Stock Ownership - AstraZeneca
Emma Donald
Employment or Leadership Position - AstraZeneca
Stock Ownership - AstraZeneca